Page 1432 - Problem-Based Feline Medicine

INDEX 1425

supraventricular/atrial tachycardia, Diverticulosis, intestinal, 735, 759 perineal inflammation/infection, 792
162 Diverticulum, 763, 779 upper respiratory tract disease in
supraventricular premature beats, D-limonene toxicity, 580, 598–599 fading kitten/neonate, 1138
166 Dobutamine, 152, 1368 Yersinia pestis, 384
Dimenhydrinate, 1367 Docusate calcium, 1368 Doxylamine succinate, 1369
Dimercaprol, 1367 Docusate sodium, 1368 Drainage
Dimercepto succinic acid (DMSA), Dolansetron, 1368 abscess, 369
660 Domestic short hair (DSH) ear infection, middle/inner, 877
Dimethylmetatolilimide (DEET), 1032 intestinal adenocarcinoma, 677 otitis media-interna, 842
Dimethylsufoxide, 1367 myasthenia gravis, 622 Dried food, pica, 1020
Diminazene aceturate, 1367, 1368 primary hyperoxaluria, 967 “Dropped-hock” gait, 963, 968
Dinoprost, 1368 pyruvate kinase deficiency, 536 Drug(s), 1342–1352
Diphacinone, 507 Domestic-tricolored cats, neuroaxonal adverse effects, 1351
Diphemanil methylsulfate, 1368 dystrophy, 934 aggression induction, 994
Diphenhydramine, 1368 Dopamine anemia from, 527, 529, 533–534,
organophosphate toxicity, 595, 862, anxiety-related behavior problems, 546
902, 948 1011 anorexia induction, 265, 268
Diphenoxylate, 1368 obsessive compulsive disorders, conjugate limits, 122
Diphenylthiocarbazone, 1368 1015 constipation/straining from, 782,
Diptheritic membrane, Mycoplasma, pancreatitis, 278 791–792
14 Dopamine agonists, acromegaly, 323 contraindicated, 510, 1342–1343,
Dipylidium caninum, 314 Dopamine hydrochloride, 1368 1345–1346
Dipyridamole, 1368 Doppler studies, atrial septal defect, dosing regimen, 1351–1352
Dipyrone, 267 145 elimination, 1345
Direct Coomb’s testing, 533 Doramectin, 1113 head tilt/vestibular ataxia/nystagmus
Dirofilaria immitis, 104, 126, 666, 691 Double-contrast cystography, 185 induction, 849–850
Dirofilariosis see Heartworm disease Doxapram, 1369 hemoglobin, 1345
Discoid lupus erythematosus, 1043 Doxorubicin, 1076–1077, 1343, 1347, hemorrhage induction, 483, 485,
Disinfectant ingestion, 580, 587–588 1369 524–525
Disodium EDTA, 1368 Doxycycline, 1369 megakaryocytic hypoplasia, 497
Disseminated intravascular coagulation anaplasmosis, 548 metabolism, feline, 1344–1345,
(DIC), 483, 484, 501–503 autoimmune dermatoses, 1043 1345
cardiomyopathy and, 915 bacterial blepharitis metabolism, general, 1344
clinical signs, 502, 507, 509 /meibomitis/hordoleum/chalazi overdose, cyanosis, 111, 117–118
diagnosis, 502 on, 1325 physiologic factors influencing
differential diagnosis, 502 bacterial rhinitis, secondary, 23 disposition, 1345
factor abnormalities, 538 Bordetella, 98 polyuria/polydipsia from, 244
liver disease, 498 Chlamydophila felis infection, 14 pyrexia induction, 367, 381
pathogenesis, 501–502 ehrlichiosis, 548 reactions/hypersensitivity,
treatment, 502–503 encephalitis, 861 1034–1035, 1061–1062
Distemper see Panleukopenia eosinophilic granuloma complex, alopecia, 1054, 1061–1062
Distichiasis, 1317, 1329 587 clinical signs, 1034–1035, 1061
Distracters, predatory aggression, 1006 feline calicivirus, 583 diagnosis, 1035, 1061–1062
Dithiazanine iodide, 1368 feline rhinotracheitis virus, 8 differential diagnosis, 1035, 1062
Diuresis hemoplasmosis, 531 megakaryocytic hypoplasia, 496
poisoning, 286 hyperthyroidism, 390 miliary dermatitis, 1024,
post-obstructive, 180, 183 immune-mediated hemolytic 1034–1035
Diuretics anemia, 533 pathogenesis, 1034, 1061
acute renal failure and, 282 inflammatory bowel disease, 673 treatment, 1035, 1062
hypercalcemia, 249 mycobacterial infections in non- therapeutically useful, 1343–1344,
hypertrophic cardiomyopathy, 131 healing wounds, 1086 1347–1350
solid tumors, 461 Mycoplasma, 14 therapy, 1351–1352
usage cautions, 131 oral inflammatory disease, 585 urine discoloration, 215